Another study reported that HSCs can mediate hepatoma progression by releasing factors that promote epithelial-mesenchymal trans-formation and angiogenesis, such as VEGF, MMP2, MMP9, bFGF, and TGF-β (27, 28). Here, MMP2 is linked to hepatocellular carcinoma.